Showing results (661-670 of 1,892) with videos related to

Sort By:
Pageof 190
Immunotherapy|December 24, 2019
In vivo tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3ε nanobody in breast cancer mice modelAzadeh Sharif Khatibi, Nasim Hayati Roodbari, Keivan Majidzade-A, et al.
Immunotherapy|March 12, 2020
Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with B2M and STK11 mutations: a case reportYi Qin, Min Yu, Lin Zhou, et al.
Immunotherapy|January 26, 2019
The promising role of monoclonal antibodies for gastric cancer treatmentFarzaneh Afshari, Saeed Soleyman-Jahi, Mahsa Keshavarz-Fathi, et al.
Immunotherapy|January 26, 2019
Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumorsAnna Schurich, Isabelle Magalhaes, Jonas Mattsson
Immunotherapy|February 1, 2019
Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantationJun Liu, Xi Zhang, Jiang F Zhong, et al.
Immunotherapy|February 1, 2019
Biologics for hidradenitis suppurativa: an updateKatarzyna Włodarek, Małgorzata Ponikowska, Łukasz Matusiak, et al.
Immunotherapy|February 18, 2020
Aggravation of depigmentation for a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: case reportYinghui Xu, Yangyang Cai, Jianjiao Zu, et al.
Immunotherapy|February 18, 2020
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitorsShipra Gandhi, Manu Pandey, Nischala Ammannagari, et al.
Immunotherapy|January 10, 2020
5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia - a summaryXian Zhang, Junfang Yang, Gailing Zhang, et al.
Immunotherapy|February 5, 2019
Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysisAndrew M Frederickson, Stella Arndorfer, Ina Zhang, et al.
Pageof 190